$2.6+ Billion Worldwide Vacuum Blood Collection Tube Industry to 2029 - Increasing Consumer Awareness of the Importance of Maintaining a Healthy Lifestyle is Driving Growth - ResearchAndMarkets.com

11 Nov 2022
www.businesswire.com
DUBLIN--(BUSINESS WIRE)--The "Vacuum Blood Collection Tube Market Report by Application, by Type, by Material, by End User, and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
'Vacuum Blood Collection Tube Market Report by Application, by Type, by Material, by End User, and by Region - Global Forecast to 2029'
The vacuum blood collection tube market size is estimated to be USD 2611.56 million in 2021 and is expected to witness a CAGR of 8.78% during the forecast period 2022-2029.
The increasing incidence of disorders, more cases of HIV and diabetes, and increasing consumer awareness of the importance of maintaining a healthy lifestyle are some of the key drivers for the market growth.
However, stringent government regulations, a shortage of experienced workers, and the risk connected with blood transfusion are expected to restrain the market growth.
Companies Mentioned
Greiner Holding (Austria)
Macopharma (France)
Smiths Medical (US)
Liuyang Sanli Medical Technology Development (China)
AB Medical (South Korea)
APTCA SPA (Italy)
Terumo BCT (US)
Jiangsu Micsafe Medical Technology CO. Ltd. (China)
Ajosha Bio Teknik Pvt. Ltd. (India)
Preq Systems (India)
Haematonics (US)
CML Biotech (India)
Mitra Industries Private Limited (India)
Grifols S.A.Grifols S.A. (Spain)
Neomedic Limited (UK)
Market Segmentation
By Application (Revenue, USD Million)
Biochemical Test
By Type (Revenue, USD Million)
Plasma Separation Tubes
Serum Blood Collection Tube
By Material (Revenue, USD Million)
By End user (Revenue, USD Million)
Clinics
Hospitals
Blood Banks
Outpatient Centres
By Region (Revenue, USD Million)
North America
U.S
Canada
Europe
Germany
France
UK
Spain
Italy
Rest of Europe
China
Japan
India
Australia
South Korea
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Rest of LATAM
Middle East & Africa
South Africa
GCC
Rest of MEA
For more information about this report visit https://www.researchandmarkets.com/r/qedguo
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.